Variant report
Variant | nsv982629 |
---|---|
Chromosome Location | chr9:118506958-118515548 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFK | chr9:118507236-118507365 | HepG2 | liver: | n/a | n/a |
2 | POLR2A | chr9:118509227-118509315 | K562 | blood: | n/a | n/a |
3 | POLR2A | chr9:118510145-118510255 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | REST | chr9:118507778-118508119 | PFSK-1 | brain: | n/a | chr9:118507935-118507944 chr9:118507930-118507950 chr9:118507930-118507950 |
5 | STAT3 | chr9:118510427-118510726 | MCF10A-Er-Src | breast: | n/a | chr9:118510463-118510471 |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PAPPA-3 | chr9:118509907-118510005 | XLOC_007533 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000228714 | TF binding region |
C16orf70 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149283594 | chr9:118506964-118506965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10817832 | chr9:118506984-118506985 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs982463 | chr9:118506991-118506992 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs534922970 | chr9:118507057-118507058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578261403 | chr9:118507081-118507082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111895538 | chr9:118507125-118507126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551227708 | chr9:118507140-118507141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571439384 | chr9:118507141-118507142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146178923 | chr9:118507208-118507209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs137887235 | chr9:118507225-118507226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182927478 | chr9:118507246-118507247 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs982464 | chr9:118507255-118507256 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs544551452 | chr9:118507270-118507271 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs374981123 | chr9:118507388-118507389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555803702 | chr9:118507434-118507435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13300130 | chr9:118507455-118507456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572432503 | chr9:118507458-118507459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541762242 | chr9:118507510-118507511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564596234 | chr9:118507530-118507531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs578181405 | chr9:118507536-118507537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543690222 | chr9:118507550-118507551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138598760 | chr9:118507556-118507557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563902342 | chr9:118507572-118507573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528981670 | chr9:118507575-118507576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534368381 | chr9:118507590-118507591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76667131 | chr9:118507594-118507595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558938474 | chr9:118507599-118507600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142197705 | chr9:118507708-118507709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188031001 | chr9:118507773-118507774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571483117 | chr9:118507789-118507790 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs530822532 | chr9:118507879-118507880 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs550551225 | chr9:118507947-118507948 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs567409692 | chr9:118507958-118507959 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs146399363 | chr9:118508008-118508009 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs555865373 | chr9:118508037-118508038 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs566101702 | chr9:118508133-118508134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192974503 | chr9:118508188-118508189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558118730 | chr9:118508201-118508202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559307153 | chr9:118508208-118508209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35306289 | chr9:118508265-118508266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10982903 | chr9:118508283-118508284 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs544046007 | chr9:118508328-118508329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs58325354 | chr9:118508329-118508330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557191205 | chr9:118508346-118508347 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542334640 | chr9:118508356-118508357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560557401 | chr9:118508389-118508390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559048238 | chr9:118508422-118508423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528156166 | chr9:118508433-118508434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184671177 | chr9:118508603-118508604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544643283 | chr9:118508613-118508614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 19147751 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 21509527 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ependymoma | 19289631 | CNVD |
Schizophrenia | 18940311 | CNVD |
Neuroticism | 17667963 | CNVD |
Cervical cancer | 17311676 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Neurodevelopmental disorder | 0 | CNVD |
Intellectual disability | 21811512 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 22522925 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:118502200-118509400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr9:118508200-118508800 | Enhancers | NH-A | brain |
3 | chr9:118508200-118509400 | Weak transcription | HMEC | breast |
4 | chr9:118508600-118509400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr9:118508600-118509600 | Enhancers | HSMM | muscle |
6 | chr9:118508800-118509600 | Weak transcription | NH-A | brain |
7 | chr9:118509400-118509800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr9:118509400-118509800 | Enhancers | HMEC | breast |
9 | chr9:118509400-118509800 | Enhancers | NHEK | skin |
10 | chr9:118509400-118510000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr9:118509400-118510400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
12 | chr9:118509600-118509800 | Enhancers | NH-A | brain |
13 | chr9:118510400-118516400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
14 | chr9:118514600-118515000 | Enhancers | A549 | lung |
15 | chr9:118515000-118518000 | Weak transcription | A549 | lung |
16 | chr9:118515400-118515600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |